Trial · NCT02978326
Participant flow27
How many started, completed or left each group, period by period.
1 to 20 of 27
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part A (Up to 75 Days) | STARTED | Part A: SAGE-217 15/20 mg Oral Solution | 1 | |
| Part A (Up to 75 Days) | STARTED | Part B: Placebo | 0 | |
| Part A (Up to 75 Days) | STARTED | Part B: SAGE 217 30 mg Capsules | 0 | |
| Part A (Up to 75 Days) | COMPLETED | Part A: SAGE-217 15/20 mg Oral Solution | 1 | |
| Part A (Up to 75 Days) | COMPLETED | Part B: Placebo | 0 | |
| Part A (Up to 75 Days) | COMPLETED | Part B: SAGE 217 30 mg Capsules | 0 | |
| Part A (Up to 75 Days) | NOT COMPLETED | Part A: SAGE-217 15/20 mg Oral Solution | 0 | |
| Part A (Up to 75 Days) | NOT COMPLETED | Part B: Placebo | 0 | |
| Part A (Up to 75 Days) | NOT COMPLETED | Part B: SAGE 217 30 mg Capsules | 0 | |
| Part B (Up to 45 Days) | STARTED | Part A: SAGE-217 15/20 mg Oral Solution | 0 | |
| Part B (Up to 45 Days) | STARTED | Part B: Placebo | 76 | |
| Part B (Up to 45 Days) | STARTED | Part B: SAGE 217 30 mg Capsules | 77 | |
| Part B (Up to 45 Days) | Received Study Drug | Part A: SAGE-217 15/20 mg Oral Solution | 0 | |
| Part B (Up to 45 Days) | Received Study Drug | Part B: Placebo | 73 | |
| Part B (Up to 45 Days) | Received Study Drug | Part B: SAGE 217 30 mg Capsules | 78 | |
| Part B (Up to 45 Days) | Safety Set (Part B) | Part A: SAGE-217 15/20 mg Oral Solution | 0 | |
| Part B (Up to 45 Days) | Safety Set (Part B) | Part B: Placebo | 73 | |
| Part B (Up to 45 Days) | Safety Set (Part B) | Part B: SAGE 217 30 mg Capsules | 78 | |
| Part B (Up to 45 Days) | Efficacy Set (Part B) | Part A: SAGE-217 15/20 mg Oral Solution | 0 | |
| Part B (Up to 45 Days) | Efficacy Set (Part B) | Part B: Placebo | 74 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02978326/flow